Trazodone Should Not Be Used for Insomnia at Any Dose, Including 25 mg
The American Academy of Sleep Medicine explicitly recommends against using trazodone for insomnia treatment, and this recommendation applies regardless of whether you split tablets to obtain lower doses like 25 mg. 1
Why This Recommendation Exists
The 2017 AASM clinical practice guideline specifically states that clinicians should NOT use trazodone as a treatment for sleep onset or sleep maintenance insomnia in adults. This recommendation was based on trials using 50 mg doses, but the underlying concern is that harms outweigh benefits for insomnia treatment 1. The evidence quality was rated as "moderate" with harms outweighing benefits.
The Core Problem
While trazodone is FDA-approved for major depressive disorder 2, it has no FDA approval for insomnia. The FDA label makes no mention of insomnia as an indication, and the recommended starting dose for depression is 150 mg/day in divided doses, not the 25-50 mg commonly used off-label for sleep 2.
Practical Considerations About Splitting Tablets
Yes, you can physically split trazodone tablets - the FDA label explicitly states that trazodone tablets "can be swallowed whole or administered as a half tablet by breaking the tablet along the score line" 2. However, being able to split the tablet doesn't make it appropriate for insomnia treatment.
Why 25 mg Doesn't Solve the Problem
- The guideline recommendation against trazodone was based on 50 mg doses, but the concern extends to lower doses because the evidence base doesn't support efficacy at any dose for primary insomnia
- While recent research suggests low-dose trazodone (25-100 mg) may improve sleep 3, 4, these studies came after the major guidelines and don't override the systematic evidence review showing harms outweigh benefits
- The FDA-recommended doses for depression (150-600 mg/day) are far higher than sleep doses, suggesting the 25-50 mg range lacks robust regulatory scrutiny 2
Serious Safety Concerns at Any Dose
Even at low doses, trazodone carries significant risks that persist regardless of tablet splitting:
- Orthostatic hypotension and syncope - can occur at any dose 2
- Priapism - painful erections >6 hours requiring emergency treatment, reported in men taking trazodone 2
- Next-morning cognitive impairment - may impair driving and hazardous activities 2
- Serotonin syndrome - when combined with other serotonergic medications 2
- Increased bleeding risk - especially with NSAIDs, aspirin, or anticoagulants 2
- Cardiac effects including QT prolongation 2
What You Should Use Instead
The AASM guideline provides clear alternatives with evidence supporting their use:
For sleep onset insomnia:
- Zaleplon 10 mg
- Triazolam 0.25 mg
- Ramelteon 8 mg
- Zolpidem 10 mg (also for maintenance)
- Eszopiclone 2-3 mg (also for maintenance)
For sleep maintenance insomnia:
- Suvorexant 10-20 mg
- Doxepin 3-6 mg (specifically studied at these LOW doses for insomnia)
- Temazepam 15 mg
- Eszopiclone 2-3 mg
- Zolpidem 10 mg
Important Note About Doxepin
If you want a low-dose antidepressant for insomnia, doxepin 3-6 mg is the evidence-based choice, not trazodone. Unlike trazodone, doxepin at these specific low doses has AASM guideline support for sleep maintenance insomnia 1.
Common Clinical Pitfall
Many clinicians use trazodone 25-50 mg for insomnia because it's "non-habit forming" compared to benzodiazepines or Z-drugs. However, this reasoning ignores the evidence showing it doesn't work well enough to justify its risks. The American College of Physicians also found insufficient or low-strength evidence for antidepressants in treating insomnia 5.
Bottom Line
Do not cut trazodone to 25 mg for sleep. The guideline recommendation against trazodone for insomnia is clear and applies regardless of dose manipulation. If you need a medication for insomnia, use one of the evidence-supported alternatives listed above. If you specifically want a low-dose, non-controlled substance option, consider doxepin 3-6 mg, which actually has guideline support for this indication.